亚洲人群中伴与不伴HIV感染的慢性病毒性肝炎患者肝细胞癌发病率与死亡率
该回顾性人群队列研究纳入2001至2018年HBV和/或HCV感染者,比较伴与不伴HIV感染者的肝细胞癌发病率与全因死亡率。伴HIV的HBV感染者肝细胞癌风险较低(校正HR 0.376),HCV及HBV-HCV合并感染者两组风险相似。
要点
- 伴HIV的HBV感染者肝细胞癌风险低于不伴HIV者(校正HR 0.376)。
- 伴HIV的HBV感染者死亡风险低于不伴HIV者(校正HR 0.692)。
- HCV及HBV-HCV合并感染中,伴与不伴HIV者肝细胞癌风险相似。
核心结论
- 在HBV感染者中,伴HIV者肝细胞癌发病率低于不伴HIV者。
- 在HCV感染者中,伴与不伴HIV者肝细胞癌发病率相似。
研究设计与样本
- 回顾性人群队列研究,纳入2001至2018年HBV和/或HCV感染者。
- 共纳入1374例伴HIV感染者和39908例不伴HIV的HBV和/或HCV感染者。
- 主要终点为肝细胞癌发病率,次要终点为全因死亡率,采用Cox比例风险回归模型估计HIV的风险比(HR)。
主要发现
- 伴HIV者中,654例(47.6%)为HBV,649例(47.2%)为HCV,71例(5.2%)为HBV-HCV合并感染;该人群更年轻,HCV患病率更高,肝硬化患病率更低。
- 肝细胞癌发病率分别为伴HIV者1.5/1000人年(95%CI 0.8-2.5)和不伴HIV者7.6/1000人年(95%CI 7.3-8.0)。
- 在HBV感染者中,HIV与较低的肝细胞癌风险相关(校正HR 0.376,95%CI 0.201-0.704,p=0.01)。
- 在HBV感染者中,HIV与较低的死亡风险相关(校正HR 0.692,95%CI 0.552-0.867,p=0.007)。
- 在HCV感染和HBV-HCV合并感染中,伴与不伴HIV者的肝细胞癌风险相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is uncertain whether people with HIV infection have a higher incidence of hepatocellular carcinoma (HCC) than the general population. AIMS: To compare the incidence of HCC between people infected with HBV and/or HCV with and without HIV METHODS: We performed a retrospective population-based cohort study, involving people with HBV and/or HCV infection from 2001 to 2018. The primary endpoint was incidence of HCC; secondary endpoint was all-cause mortality. We performed Cox proportional hazard regression models to estimate the hazard ratios (HR) of HIV for the primary and secondary endpoints. RESULTS: We identified 1374 people infected with HIV and 39,908 people without HIV with HBV and/or HCV infection. Among those with HIV, 654 (47.6%) had HBV, 649 (47.2%) HCV and 71 (5.2%) HBV-HCV-co-infection; they were younger, and had a higher prevalence of HCV and a lower prevalence of cirrhosis. The incidence rate estimates of HCC were, respectively, 1.5 (95% CI: 0.8-2.5) and 7.6 (95% CI 7.3-8.0) per 1000 person-years for those with and without HIV infection. Using multivariate Cox proportional hazard regression models, among people with HBV, HIV was associated with lower risk of HCC (adjusted HR: 0.376, 95% CI: 0.201-0.704, p = 0.01) and death (adjusted HR: 0.692, 95% CI: 0.552-0.867, p = 0.007). Risks of HCC were similar for HCV and HBV-HCV co-infection for people with and without HIV. CONCLUSIONS: Among individuals with HBV infection, the Incidence of HCC was lower in those with HIV. For HCV infection, incidence of HCC was similar between those with and without HIV.
引用
- Lui GC, Hui VW, Sze SF, et al. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection. Aliment Pharmacol Ther. 2023. PMID: 37515399. doi:10.1111/apt.17654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。